This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Agency for Science, Technology and Research. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Thomas Joseph - Innovator in Cancer Treatment Peptides
Introduction
Thomas Joseph is a notable inventor based in Singapore, SG. He has made significant contributions to the field of cancer treatment through his innovative work on peptides. His research focuses on non-membrane disruptive and p53 activating stapled peptides, which have the potential to revolutionize cancer therapies.
Latest Patents
Thomas Joseph holds a patent for "Non-membrane disruptive P53 activating stapled peptides." This invention relates to peptides that activate the p53 protein, which plays a crucial role in regulating the cell cycle and preventing cancer. The patent describes peptides that consist of specific amino acid sequences, which can be utilized in methods of cancer treatment.
Career Highlights
Thomas Joseph is affiliated with the Agency for Science, Technology and Research, where he conducts his research and development. His work has garnered attention for its potential applications in oncology, particularly in enhancing the effectiveness of cancer treatments.
Collaborations
Thomas collaborates with esteemed colleagues, including Yaw Sing Tan and Fernando Jose Ferrer Gago. Their combined expertise contributes to the advancement of research in the field of cancer treatment.
Conclusion
Thomas Joseph's innovative work in developing p53 activating stapled peptides represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of research and collaboration in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile